Kamuvudine-9 (K9) in Diabetic Macular Edema

Clinical trial NCT07458061 · RECRUITING

Trial details

NCT number: NCT07458061
Sponsor: Dr. Bryan Strelow
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2026-02-01
Primary completion: 2026-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.